China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
Home Office squandered billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
Home Office squandered billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.